SHOC2 Is a Novel Cause of Central Conducting Lymphatic Anomaly.

Am J Med Genet AJul 15, 2026 (epub)

Jessica C Ding, Benjamin A Sempowski, Lola Zerbib et al.

✦ AI-curated · Sources linked

Case in brief

A patient with complex congenital heart disease developed refractory chylothorax after surgery. Lymphatic imaging showed abnormal intercostal lymphatic perfusion consistent with central conducting lymphatic anomaly (CCLA) and suggestive of a RASopathy. Genetic testing identified a SHOC2 p.(Ala308Val) variant of uncertain significance. Functional studies supported pathogenicity: zebrafish expressing the variant developed pericardial edema, caudal plexus cystic malformations, and thoracic duct dilation. Trametinib treatment did not improve the patient’s condition; immunoblot findings suggested a possible non-canonical mTOR mechanism.

What made this case unusual

The case links a SHOC2 variant to CCLA, with functional evidence of lymphatic malformations and findings suggesting a non-canonical mTOR mechanism rather than the expected RAS-MAPK pathway.

Diagnostic / clinical pearl

In refractory postoperative chylothorax, lymphatic imaging can reveal CCLA; genetic and functional evaluation may help assess a variant of uncertain significance when a RASopathy is suspected.

Source

Published in Am J Med Genet A. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Medical Genetics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.